Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Early diagnosis of prostate cancer in finasteride treated BPH patients (CROSBI ID 119225)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Tarle, Marko ; Kraus, Ognjen ; Trnski, Davor ; Reljić, Ante ; Ružić, Boris ; Katušić, Josip ; Spajić, Borislav ; Kusić, Zvonko Early diagnosis of prostate cancer in finasteride treated BPH patients // Anticancer Research, 23 (2003), 1B; 693-696-x

Podaci o odgovornosti

Tarle, Marko ; Kraus, Ognjen ; Trnski, Davor ; Reljić, Ante ; Ružić, Boris ; Katušić, Josip ; Spajić, Borislav ; Kusić, Zvonko

engleski

Early diagnosis of prostate cancer in finasteride treated BPH patients

It appears that in finasteride treated patients with large prostate (>60 cc) the application of finasteride may facilitate an early detection of prostate cancer by lowering %FPSA data from >18% values to much lower levels while TPSA drops much less than down to 50% of its initial value. According to these recordings it is easy to diagnose an early prostate cancer in patients with a large prostate that prevents an accurate clinical finding.

BPH; Finasteride; continuous and intermittend therapy; prostate cancer

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

23 (1B)

2003.

693-696-x

objavljeno

0250-7005

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost